No Data
CH BIOTECH SER (08037): Hubei Weiyou plans to invest up to 50 million yuan in Pengbo (Hainan).
CH BIOTECH SER (08037) released an announcement on February 27, 2025, Pengbo (Hainan), Dy...
Express News | China Biotech Services - Registered Capital of Pengbo (Hainan) to Increase to RMB166.7 Mln
CH BIOTECH SER (08037.HK) signed a Global Strategy cooperation framework agreement with Shenzhen BGI Genomics.
On February 25, Gelonghui announced that CH BIOTECH SER (08037.HK) entered into a strategic cooperation framework agreement with BGI Genomics on February 25, 2025; and (ii) Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. ("Pengbo (Hainan)") (a wholly-owned subsidiary of the company) has signed a letter of intent for investment with Shenzhen BGI Songhe Biotechnology Fund No. 1 Private Equity Venture Capital Partnership (Limited Partnership) ("Investor"), regarding the investment that the investor intends to make in Pengbo (Hainan). BGI and the company in tumor precision.
Express News | China Biotech Services - Under Framework Agreement Parties to Jointly Conduct Academic Research on Novel Cd20-Targeted CAR-T Therapy, Others
Express News | China Biotech Services - Letter of Intent on Investment in Pengbo (Hainan) Medical Technology
Express News | China Biotech Services - Strategic Cooperation Framework Agreement With Shenzhen Bgi Technology
Some China Biotech Services Holdings Limited (HKG:8037) Shareholders Look For Exit As Shares Take 30% Pounding
